bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage lung cancer and other lung diseases, today ...
bioAffinity Technologie announced that the Australian Patent Office or IP Australia, has accepted bioAffinity’s patent application for the method of predicting the likelihood of lung cancer used ...
In this interview, Technology Networks spoke with Dr. Sophie Mayle, Dr. Paul Royle and Dr. John Cardone from Bio-Rad's ...
SAN ANTONIO, January 22, 2025--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback